Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | MRD positivity and associated reduction in MM PFS

Jesus San Miguel, MD, of The Univeristy of Navarra Clinic, Pamplona, Spain, discusses the longer survival of measurable residual disease (MRD) negative patients compared to MRD positive, and the best methods for studying lesions. This interview was recorded at the International Myeloma Workshop, in Boston, MA.